Pharvaris is a Switzerland-based pharmaceutical company that develops and commercializes therapies for the treatment of hereditary angioedema.
Business Model:
Revenue: $0
Employees: 11-50
Address: Grafenauweg 8
City: Zug
State: zug
Zip: CH-6300
Country: CH
Pharvaris is a Switzerland-based pharmaceutical company that develops and commercializes therapies for the treatment of hereditary angioedema.
Contact Phone:
+16469425631
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/4/2021
IPO Valuation:
$637M
Ticker Symbol:
PHVS
IPO Price:
$20/share
Amount Raised:
$165M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | IPO | $165.4M | 9/2019 | Series B | 7 | $66M |
Venrock Foresite Capital Kurma Partners Foresite Capital venBio Partners Idinvest Partners EQT life science Bain Capital Life Sciences Venrock Foresite Capital Kurma Partners Foresite Capital |
1/2016 | Series A | 3 | $16.3M |
Kurma Partners Idinvest Partners EQT life science Kurma Partners |
4/2016 | Series A | $16.9M |
Kurma Partners Life Sciences Partners |
11/2020 | Series C | 7 | $80M |
Cormorant Asset Management Venrock venBio Partners General Atlantic Viking Global Investors Bain Capital Life Sciences Foresite Capital General Atlantic Viking Global Investors Cormorant Asset Management Venrock venBio Partners General Atlantic Viking Global Investors Bain Capital Life Sciences Foresite Capital General Atlantic Viking Global Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|